Our work focuses on the detailed molecular characterization of a patient being a carrier of a pathogenic variant and a hypomorphic variant in BRCA2 that survived to adulthood with mild Fanconi Anemia-associated clinical features, but nonetheless developed young-onset breast cancer and had fatal evolution. The gene discussed is BRCA2; the disease is breast carcinoma.